Repligen Reports Fourth Quarter and Year 2015 Financial Results

Go back to Repligen Reports Fourth Quarter and Year 2015 Financial Results

Repligen (RGEN) Reports In-Line Q4 EPS

February 25, 2016 7:32 AM EST

Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $21.4 million versus the consensus estimate of $19.84 million.

Tony J. Hunt, President and Chief Executive Officer said, 2015 was a great year for... More